last
decad
seen
huge
increas
amount
omic
data
avail
abil
interpret
data
aim
paper
consid
omic
techniqu
use
improv
refin
microbiolog
risk
assess
use
doserespons
model
rna
virus
particular
refer
noroviru
oral
rout
case
studi
doserespons
model
initi
infect
gastrointestin
tract
broken
compon
step
molecular
level
feasibl
assign
probabl
step
assess
molecular
mechan
suffici
well
understood
present
enabl
quantit
estim
probabl
basi
omic
data
present
great
strength
gene
sequenc
data
appear
give
inform
distribut
proport
suscept
genotyp
exampl
due
presenc
appropri
pathogenbind
receptor
host
popul
rather
predict
specif
amino
acid
sequenc
concurr
obtain
natur
mutant
spectrum
rna
virus
greatli
complic
applic
omic
approach
develop
mechanist
doserespons
model
prevent
predict
risk
diseas
progress
given
infect
occur
level
individu
host
howev
molecular
marker
host
viru
may
enabl
broad
predict
made
consequ
exposur
popul
altern
approach
compar
result
deep
sequenc
rna
virus
faecesvomitu
donor
human
infect
recipi
may
enabl
direct
estim
averag
probabl
infect
per
virion
made
appli
omic
doserespons
relationship
p
gale
et
al
classic
microbiolog
risk
assess
mra
consist
four
step
hazard
identif
hazard
character
exposur
assess
risk
character
cac
wealth
literatur
subject
mra
develop
mani
pathogencommod
combin
span
wide
rang
food
type
readytoeat
produc
anim
product
cook
home
eg
cassin
et
al
gale
nauta
et
al
despit
potenti
contribut
mra
use
omic
data
mra
date
limit
therefor
aim
paper
elucid
omic
data
techniqu
use
gener
analys
data
use
improv
andor
complement
mra
identifi
barrier
may
exist
incorpor
omic
data
mra
consid
futur
omic
data
may
prove
use
focu
human
oral
doserespons
relationship
drr
molecular
process
govern
pathogenhost
interact
establish
also
known
data
gap
drr
journal
appli
microbiolog
societi
appli
microbiolog
mani
pathogencommod
combin
drr
use
translat
exposur
oral
rout
risk
infectiondiseas
classic
mra
drr
base
human
studi
differ
dose
fed
group
volunt
ward
et
al
proport
infect
ill
dose
plot
dose
mathemat
model
fit
data
use
predict
probabl
infect
dose
includ
volunt
studi
haa
et
al
teuni
et
al
last
decad
huge
increas
amount
omic
data
avail
abil
interpret
data
use
bioinformat
techniqu
genom
introduct
highthroughput
nextgener
sequenc
ng
technolog
greatli
increas
capabl
sequenc
whole
genom
individu
live
organ
rapidli
cheapli
provid
inform
variat
across
host
popul
pareek
et
al
ng
also
enabl
deep
sequenc
viral
genom
effect
give
sequenc
everi
viru
exposur
dose
term
mutant
spectrum
bull
et
al
proteom
allow
identif
protein
import
cell
given
situat
neidhardt
rel
proport
protein
repres
protein
signatur
chang
respons
challeng
could
use
identifi
protein
express
host
cell
respons
infect
viru
exampl
great
potenti
proteom
abl
detect
previous
unknown
protein
assign
cellular
locat
contact
protein
marchadi
et
al
anoth
approach
consid
glycoproteom
mani
protein
particularli
cell
pathogen
surfac
host
immun
system
sugar
unit
call
glycan
ad
inde
glycan
serv
receptor
cell
surfac
number
pathogen
includ
noroviru
nov
glycoproteom
character
protein
contain
glycan
glycosyl
synthesi
glycan
still
remain
practic
unexplor
proteom
scale
doerr
rel
pathogen
human
volunt
doserespons
data
avail
gener
data
absent
newli
emerg
pathogen
anim
model
use
togeth
calibr
human
outbreak
data
teuni
et
al
techniqu
need
obtain
drr
paramet
furthermor
account
need
taken
suscept
member
human
popul
focu
first
part
paper
develop
mechanist
doserespons
model
estim
probabl
initi
infect
oral
rout
second
part
paper
consid
excit
possibl
ng
data
viru
isol
donor
recipi
human
case
may
facilit
direct
estim
probabl
initi
infect
final
part
address
problem
appli
omic
approach
predict
diseas
progress
spread
tissu
infect
establish
gastrointestin
tract
nov
select
exampl
demonstr
concept
doserespons
data
human
volunt
studi
teuni
et
al
togeth
wealth
molecular
inform
receptor
bind
pathogen
omicsbas
approach
estim
probabl
initi
infect
viru
oral
exposur
infect
oral
pathogen
defin
multipl
organ
within
host
follow
excret
haa
et
al
biolog
infect
process
viru
nov
compris
number
step
set
tabl
pathogen
particl
genom
form
probabl
p
ij
initi
infect
host
individu
genom
form
j
probabl
p
ij
express
p
xij
probabl
viru
particl
complet
step
x
four
step
tabl
human
j
calcul
p
ij
everi
j
host
popul
everi
viru
popul
would
allow
definit
drr
initi
infect
rel
proport
genom
form
viru
human
popul
known
ng
conceiv
gene
sequenc
least
js
could
avail
futur
thu
give
rel
proport
genom
form
data
requir
feasibl
assign
quantit
probabl
p
xij
step
tabl
discuss
use
nov
primari
case
studi
probabl
pathogen
overcom
immedi
host
defenc
reach
cellular
receptor
number
immedi
host
defenc
mouth
gastrointestin
tract
includ
mucu
barrier
microbi
interfer
decoy
receptor
innat
immun
system
histoblood
group
antigen
hbga
glycan
certain
virus
includ
nov
rotaviru
select
bind
hbga
present
decoy
receptor
saliva
mucin
main
protein
compon
mucu
boshuizen
et
al
huang
et
al
mcguckin
et
al
shanker
et
al
propos
local
flexibl
viral
capsid
protein
could
allow
nov
disassoci
salivari
hbga
due
ph
chang
passag
gastrointestin
tract
howev
molecular
mechan
understood
problem
estim
p
effect
ph
protein
structur
go
difficult
predict
gene
sequenc
complic
mucin
product
increas
rotaviru
infect
mechan
involv
innat
immun
system
pathogen
helicobact
pylori
suppress
synthesi
gastric
mucin
mcguckin
et
al
thu
inform
p
one
pathogen
appli
anoth
mucin
glycosyl
pattern
chang
age
host
alter
antivir
capabl
boshuizen
et
al
mcguckin
et
al
provid
molecular
basi
understand
variat
p
age
host
gastrointestin
tract
microbiota
prevent
enter
diseas
pathogen
includ
rotaviru
trait
refer
colon
resist
microbi
interfer
wardwel
et
al
howev
relationship
gastrointestin
virus
commens
bacteria
gut
microbi
popul
affect
infect
enter
virus
well
understood
wardwel
et
al
interestingli
microbiota
modul
mucin
product
glycosyl
mcguckin
et
al
therefor
indirectli
affect
p
sequenc
human
microbiom
provid
deep
genet
perspect
individu
bacteria
hmp
thu
shed
light
hostpathogenmicrobiom
interact
although
difficult
translat
estim
p
innat
immun
system
provid
immedi
defenc
host
pathogen
nonspecif
gener
manner
central
innat
immun
system
recognit
specif
repeat
structur
pathogenassoci
molecular
pattern
pamp
pathogen
pathogen
recognit
receptor
prr
host
de
kone
et
al
goal
toward
develop
mechanist
drr
would
predict
whether
pamp
given
pathogen
could
detect
prr
given
host
j
requir
understand
molecular
structur
prr
combin
pamp
ligand
crystal
structur
prr
protein
complex
pathogen
pamp
ligand
publish
takeuchi
akira
combin
genom
data
could
assist
predict
strength
bind
differ
individu
howev
predict
effect
chang
gene
sequenc
bind
may
straightforward
although
polymorph
host
prr
gene
attenu
recognit
pathogen
pamp
ligand
amino
acid
correspond
polymorph
seem
directli
contact
ligand
molecul
case
salmonella
flagellin
least
uenishi
et
al
inde
differ
may
subtl
yet
understood
innat
immun
system
distinguish
commens
bacteria
pathogen
bacteria
friend
foe
de
kone
et
al
furthermor
numer
prr
recogn
differ
part
viru
triantafil
et
al
give
altern
pathway
greatli
complic
estim
probabl
viru
escap
innat
immun
system
prior
bind
cellular
receptor
step
viru
fail
bind
receptor
cell
lumen
gastrointestin
tract
pass
harmlessli
bind
viru
receptor
host
cell
surfac
highli
specif
molecular
interact
control
host
cell
suscept
henc
defin
cell
type
tissu
infect
tissu
tropism
bind
nov
capsid
protein
hbga
receptor
tabl
breakdown
initi
infect
process
four
step
build
mechanist
doserespons
relationship
rna
virus
oral
rout
inform
need
step
descript
current
inform
gap
understand
requir
overcom
initi
host
defenc
includ
mucu
barrier
microbiom
decoy
receptor
innat
immun
system
reach
cellular
receptor
gastrointestin
tract
mechan
dissoci
viru
decoy
receptor
mucu
chang
glycosyl
mechan
microbi
interfer
bind
virion
cellular
receptor
gastrointestin
tract
predict
specif
glycan
bind
virus
genet
marker
resist
frequenc
specif
allel
host
popul
entri
virion
host
cell
better
understand
proteolyt
cleavag
viral
protein
host
cell
proteas
replic
viru
infect
cell
give
mutant
cloud
capsid
assembl
proteom
may
facilit
identif
host
proteinviru
protein
interact
control
regulatori
pathway
within
infect
cell
microbiom
includ
indigen
bacteria
gastrointestin
tract
decoy
receptor
host
molecul
mop
virus
reach
target
cell
intestin
cell
well
understood
molecular
level
xray
crystallographi
studi
bu
et
al
choi
et
al
ultim
goal
would
predict
pathogen
bind
basi
nucleotid
sequenc
viral
capsid
protein
known
ultim
predict
structur
hbga
glycan
receptor
howev
despit
high
conserv
amino
acid
residu
viral
capsid
protein
interact
hbga
sequenc
similar
predictor
hbga
bind
pattern
bull
white
inde
close
relat
capsid
display
distinct
hbga
bind
pattern
wherea
genet
unrel
capsid
separ
genogroup
display
compar
hbga
bind
pattern
bull
white
complic
applic
omic
approach
predict
pathogen
specif
viral
protein
sequenc
henc
estim
p
complic
structur
nov
genogroup
gi
gii
complex
hbga
reveal
differ
mode
interact
hansman
et
al
nov
recogn
hbga
distinct
straindepend
manner
shanker
et
al
nov
constantli
evolv
antigen
drift
capsid
protein
give
differ
hbga
bind
specif
shanker
et
al
genom
data
togeth
crystal
structur
data
could
use
identifi
chang
surfac
moieti
viral
capsid
although
interpret
impact
function
may
difficult
exampl
observ
ng
fmdv
laboratoryinfect
cattl
wright
et
al
laboratori
strain
viru
sever
posit
charg
amino
acid
coat
protein
select
neg
charg
heparin
sulphat
cell
cultur
cow
posit
charg
revert
rotaviru
target
intestin
epithelium
known
exactli
cell
intestin
nov
bind
chan
et
al
develop
mechanist
drr
requir
know
cell
target
initi
viru
differ
cell
express
differ
surfac
protein
conclud
even
best
understood
system
predict
p
individu
viru
x
human
j
interact
extrem
difficult
use
genom
data
assess
proport
host
popul
resist
viru
basi
receptor
bind
step
genet
resist
nov
infect
provid
excel
exampl
genet
marker
could
use
calibr
mechanist
drr
lindesmith
et
al
report
human
studi
one
popul
homozyg
recess
gene
unabl
synthes
function
enzym
make
glycan
part
hbga
receptor
nov
bind
popul
express
receptor
requir
nov
bind
thu
highli
protect
nov
infect
p
inde
none
individu
develop
infect
exposur
howev
larg
dose
viru
ingest
european
highli
protect
categori
kindberg
svensson
de
rougemont
et
al
could
accur
calcul
dissoci
constant
nov
hbga
receptor
although
associ
like
strong
thu
case
nov
may
possibl
simplifi
step
assum
p
individu
genet
suscept
function
gene
p
genet
resist
nonfunct
gene
simplifi
calibr
p
drr
determin
proport
popul
resist
applic
genom
approach
particularli
well
suit
howev
possibl
pathogen
could
use
altern
receptor
would
need
elimin
case
bacterium
h
pylori
known
use
carbohydr
receptor
addit
hbga
de
matto
p
sum
probabl
parallel
rout
differ
p
valu
breakdown
volunt
doserespons
data
ward
et
al
two
compon
model
propos
previous
rotaviru
gale
howev
unlik
case
nov
limit
molecular
data
bind
rotaviru
receptor
inde
genet
basi
variat
popul
suscept
also
bind
process
rotaviru
may
complic
nov
sever
cell
surfac
molecul
implic
isa
et
al
evid
rotaviru
surfac
protein
may
open
tight
junction
cell
intestin
lumen
allow
access
bind
basal
side
cell
nava
et
al
boshuizen
et
al
addit
apic
side
cell
use
nov
predict
sequenc
event
would
difficult
even
proteom
approach
identifi
hub
proteinprotein
interact
involv
probabl
host
cell
entri
p
viru
given
bound
cellular
receptor
step
depend
virus
least
effici
cleavag
viral
protein
host
cell
proteolyt
enzym
specif
cleavag
process
typic
occur
newli
synthes
virion
releas
cell
previou
round
infect
abil
host
cell
proteolyt
enzym
cleav
viral
protein
may
control
entri
cell
next
round
infect
case
highli
pathogen
avian
influenza
viru
tissu
tropism
pathogen
determin
whether
host
cell
proteolyt
enzym
cleav
viral
haemagglutinin
protein
explain
abil
highli
pathogen
avian
influenza
strain
replic
mani
organ
outsid
respiratori
tract
thu
defin
highli
pathogen
phenotyp
chaipan
et
al
predict
p
depend
part
abl
predict
whether
viral
protein
specif
cleav
ie
right
place
also
effici
cleav
tradit
biochemistrybioinformat
problem
depend
understand
structur
viru
protein
mechanismspecif
host
proteolyt
enzym
thu
exampl
misasi
et
al
found
specif
differ
requir
filovirus
host
cell
proteolyt
enzym
call
cathepsin
b
correl
sequenc
polymorph
residu
viral
glycoprotein
use
cathepsin
proteas
host
factor
viru
entri
gener
properti
member
filoviru
famili
author
abl
predict
newli
identifi
ebola
viru
cathepsin
b
depend
approach
may
applic
assess
cell
entri
requir
virus
futur
would
contribut
understand
p
differ
host
cell
type
respect
rate
cleavag
differ
tissu
would
affect
magnitud
p
cell
entri
sar
coronaviru
also
requir
cleavag
viru
spike
protein
cellular
cathepsin
bosch
et
al
mechan
nov
entri
clear
although
evid
proteolyt
process
could
necessari
replic
tan
et
al
isol
virus
cell
cultur
reli
replic
viru
within
cell
use
sever
type
cell
cultur
provid
suitabl
environ
mani
virus
leland
ginocchio
inde
transgen
express
appropri
receptor
step
may
make
previous
nonsuscept
cell
suscept
eg
polioviru
pv
leland
ginocchio
thu
default
posit
step
would
assum
p
viral
rna
replic
capsid
synthesi
assembl
occur
host
cell
given
viru
nucleoprotein
core
gain
entri
step
support
replic
viral
rna
perform
rnadepend
rna
polymeras
rdrp
present
viru
core
synthesi
new
viru
capsid
protein
take
place
host
cell
ribosom
inde
viral
protein
seiz
control
cellular
translat
factor
host
signal
pathway
ensur
viral
protein
produc
also
stifl
innat
host
defenc
limit
capac
infect
cell
produc
viru
walsh
mohr
understand
regul
pathway
may
enabl
refin
estim
p
thu
virus
commonli
use
host
cell
surviv
mechan
advantag
particular
pathway
suppress
apoptosi
program
cell
death
give
time
complet
viral
replic
eden
et
al
phosphoryl
nov
rdrp
host
akt
pathway
decreas
polymeras
activ
eden
et
al
may
antivir
strategi
consid
estim
p
central
understand
viru
replic
step
applic
proteom
determin
proteinprotein
contact
situ
infect
cell
thu
individu
viru
protein
associ
host
cell
protein
henc
work
togeth
envisag
proteom
techniqu
could
use
identifi
hub
virusinfect
host
cell
similar
way
bacterium
bacillu
subtili
marchadi
et
al
import
assess
infect
viru
term
drr
viral
protein
interact
host
protein
differ
hub
mani
correspond
regulatori
pathway
marchadi
et
al
proteom
analysi
use
mass
spectrometri
human
host
protein
associ
rdrp
avian
influenza
viru
identifi
protein
may
role
induct
apoptosi
innat
antivir
signal
cellular
rna
polymeras
accessori
factor
involv
regul
gene
express
cell
bradeltretheway
et
al
proteom
data
identifi
host
cell
protein
bound
viral
polymeras
defin
protein
hub
may
enhanc
understand
viru
replic
assembl
would
enabl
qualit
refin
estim
p
nov
exampl
rna
viru
inde
mani
virus
infect
human
includ
pv
hepat
c
viru
hcv
human
immunodefici
viru
hiv
rna
genom
differ
dna
pathogen
bacteria
protozoa
replic
viral
rna
infect
cell
step
prone
error
smidanski
et
al
gener
cloud
mutant
ie
progeni
virion
differ
sequenc
albeit
one
two
base
call
mutant
spectrum
central
quasispeci
theori
laur
andino
key
point
individu
virus
excret
infect
person
faec
vomitu
therefor
present
oral
exposur
slightli
differ
sequenc
albeit
relat
ng
deep
sequenc
provid
sequenc
viral
variant
exposur
togeth
rel
frequenc
ie
mutant
spectrum
use
detect
minor
sequenc
variant
number
human
virus
wright
et
al
clearli
import
first
step
make
predict
drr
inde
ng
rna
virus
recov
infect
person
may
give
indic
number
virion
initi
infect
shown
case
hcv
hiv
infect
aris
singl
variant
often
repres
initi
infect
one
viral
particl
wang
et
al
bull
et
al
moreov
infect
process
may
repres
bottleneck
one
two
viral
variant
exposur
dose
success
establish
infect
thu
case
nov
minor
variant
frequenc
low
success
transmit
establish
new
infect
bull
et
al
suggest
risk
infect
nov
virion
averag
approx
assum
exposur
dose
high
like
faec
vomitu
complet
spectrum
variant
present
everi
nov
high
probabl
infect
bull
et
al
would
seen
rang
nov
sequenc
infect
person
correspond
individu
virion
exposur
dose
inde
two
major
variant
donor
person
account
variant
present
either
two
recipi
person
similarli
hcv
one
two
viral
variant
success
establish
infect
wang
et
al
wang
et
al
write
noth
data
rule
possibl
mani
addit
particl
initi
inoculum
replic
new
host
rais
question
mani
virus
dose
origin
exposur
event
low
even
neglig
probabl
infect
due
bottleneck
number
footandmouth
diseas
viru
fmdv
rna
moleculesml
serum
measur
infect
pig
rtpcr
three
four
order
magnitud
higher
number
plaqueform
unit
pfu
measur
convent
method
rodriguezcalvo
et
al
thu
pfu
dosag
human
rotaviru
volunt
studi
ward
et
al
may
also
compris
mani
individu
virion
consist
id
high
term
virion
thu
although
haa
et
al
estim
risk
infect
one
pfu
rotaviru
pfu
may
compris
thousand
virion
inconsist
result
bull
et
al
nov
suggest
id
order
virion
get
bottleneck
initi
infect
thu
probabl
infect
virion
accord
neg
exponenti
doserespons
model
virion
would
need
chanc
infect
ng
data
viral
mutant
spectrum
give
complementari
inform
step
mechanist
infect
process
tabl
thu
bull
et
al
specul
nov
variant
bind
hbga
step
effect
filter
major
nov
variant
exposur
repres
bottleneck
inde
minor
variant
transmit
differ
domin
donor
variant
amino
acid
chang
directli
adjac
primari
hbga
bind
site
capsid
hiv
variant
respons
establish
infect
new
host
uniqu
phenotyp
properti
contribut
establish
infect
specif
amino
acid
increas
viral
entri
effici
step
well
uniqu
glycosyl
pattern
aid
attach
host
receptor
step
bull
et
al
thu
challeng
develop
mechanist
drr
initi
infect
determin
variant
import
given
step
tabl
central
diseas
progress
viral
pathogenesi
rna
virus
fidel
replic
rdrp
smidanski
et
al
control
complex
mutant
spectrum
produc
step
spread
pv
exampl
nervou
system
secondari
initi
establish
infect
gastrointestin
tract
thu
pv
titr
peak
small
intestin
brain
day
respect
vignuzzi
et
al
differ
individu
progeni
virus
mutant
spectrum
differ
cell
tissu
tropism
reflect
specif
gene
sequenc
compar
origin
infect
viru
specif
pv
mutant
highfidel
rdrp
ie
produc
reduc
rang
variant
replic
small
intestin
kidney
spleen
fail
reach
brain
spinal
cord
produc
neuropatholog
mice
vignuzzi
et
al
howev
restor
standard
mutant
spectrum
complex
subject
mutant
pv
chemic
mutagenesi
led
neuropathogen
mutant
spectrum
viru
reach
brain
spinal
cord
vignuzzi
et
al
smidanski
et
al
thu
enhanc
opportun
cooper
divers
clade
mutant
spectra
aris
high
mutat
rate
facilit
viru
reach
specif
target
organ
therebi
increas
viral
load
chanc
transmiss
howev
much
genotyp
variabl
may
retard
progress
viru
infect
produc
mani
defect
variant
smidanski
et
al
conclus
smidanski
et
al
rdrp
fidel
tune
natur
select
achiev
optim
genotyp
divers
mutant
spectrum
consequ
viral
competit
dynam
hostil
environ
host
cell
furthermor
level
divers
type
divers
need
may
chang
differ
tissu
differ
host
challeng
encount
may
also
chang
infect
cycl
may
vari
depend
rout
transmiss
wright
et
al
bull
et
al
bull
et
al
specul
deep
sequenc
may
yet
identifi
differ
nov
transmit
faec
compar
vomitu
exampl
huge
complex
interact
togeth
lack
understand
rdrp
control
fidel
molecular
level
smidanski
et
al
sever
limit
predict
diseas
progress
complic
host
respons
pathogen
also
dynam
host
hbga
specif
nov
chang
time
togeth
chang
host
mucin
glycosyl
rotaviru
infect
mucin
becom
potent
inhibit
viru
boshuizen
et
al
also
evid
diseas
progress
could
certain
extent
depend
chanc
ie
probabilist
thu
deep
sequenc
shown
fmdv
may
take
differ
evolutionari
trajectori
even
within
cow
albeit
differ
isol
compart
name
front
left
foot
vs
back
right
foot
wright
et
al
specif
confound
predict
individu
host
although
possibl
present
interpret
pathogen
potenti
viral
gene
sequenc
exampl
marker
viru
sequenc
known
associ
diseaserel
trait
thu
amino
acid
threonin
residu
posit
rdrp
associ
pandem
potenti
nov
gii
eden
et
al
case
fmdv
cattl
amino
acid
chang
one
four
capsid
protein
associ
persist
infect
horsington
zhang
identif
marker
may
enabl
broad
predict
made
diseas
potenti
popul
genet
marker
host
may
give
indic
resist
diseas
progress
abl
mount
effect
immun
respons
exampl
understand
polymorph
prr
gene
wang
et
al
human
leucocyt
antigen
hla
gene
hoof
et
al
togeth
interferon
code
region
thoma
et
al
may
indic
proport
popul
abl
mount
effect
respons
rna
viru
hcv
hla
protein
present
viral
peptid
cell
acquir
immun
respons
well
document
individu
person
differ
hla
protein
protect
other
virus
includ
hiv
wang
et
al
hcv
hepat
b
viru
herp
simplex
type
viru
hoof
et
al
found
protect
hla
molecul
show
prefer
present
peptid
fragment
conserv
hcv
protein
eg
core
nonprotect
hla
molecul
preferenti
target
hcv
protein
significantli
less
conserv
eg
taken
togeth
analysi
suggest
target
constrain
therebi
conserv
part
hcv
genom
protect
hla
molecul
reduc
potenti
hcv
escap
cytotox
tcell
respons
infect
host
thu
may
possibl
predict
viral
clearanc
type
viral
protein
present
hla
carlsson
et
al
identifi
capsid
residu
nov
evolutionarili
conserv
xray
crystallographi
structur
avail
human
hla
molecul
bound
viral
peptid
includ
sar
coronaviru
roder
et
al
studi
swine
leucocyt
antigen
porcin
hla
equival
complex
peptid
pandem
influenza
viru
ebola
viru
recent
publish
zhang
et
al
howev
predict
whether
conserv
less
conserv
peptid
fragment
present
hla
effect
viral
peptid
present
purpos
estim
diseas
progress
difficult
addit
problem
glycan
play
role
antigen
present
hla
glycosyl
perhap
finetun
bind
properti
ryan
cobb
viral
protein
target
hla
protein
interfer
antigen
present
roder
et
al
viral
countermeasur
diseas
progress
includ
abil
nov
capsid
evolv
evad
memori
immun
respons
escap
herd
immun
retain
abil
bind
sever
hbga
thu
mani
individu
suscept
reinfect
nov
lindesmith
et
al
ng
viral
sequenc
may
allow
identif
immun
escap
mutat
impair
abil
tcell
respons
neutral
antibodi
maintain
immun
control
shown
henn
et
al
rapid
lowfrequ
viral
variant
detect
convent
sequenc
approach
demonstr
applic
genom
understand
dynam
interplay
immun
control
virus
exampl
porcin
reproduct
respiratori
syndrom
viru
prrsv
prevent
protect
immun
respons
suppress
certain
host
gene
exampl
use
transcriptom
wysocki
et
al
compar
differ
rna
lung
high
low
prrsv
burden
pig
found
high
burden
pig
express
cellular
gene
associ
host
protect
delay
review
summar
potenti
applic
omic
approach
develop
drr
infect
oral
rout
rna
virus
view
better
defin
role
omic
data
mra
specif
issu
drr
address
omic
data
eg
estim
resistantsuscept
ratio
host
clearli
area
substanti
progress
understand
molecular
interact
requir
omic
data
appli
mra
ever
appli
although
virus
far
fewer
gene
bacteri
pathogen
natur
mutant
spectrum
case
rna
virus
greatli
complic
applic
omic
approach
develop
mechanist
doserespons
model
compound
fact
frequenc
import
variant
initi
infect
low
case
nov
hcv
wang
et
al
bull
et
al
rais
question
sequenc
look
term
specif
interact
host
initi
infect
process
gastrointestin
tract
broken
four
mechanist
step
tabl
breadth
field
consid
step
demonstr
need
multidisciplinari
approach
includ
omic
data
also
convent
biochemistri
molecular
biolog
input
provid
detail
molecular
compon
step
thu
current
protein
structur
determin
crystallographi
studi
underpin
understand
specif
molecular
interact
eg
prr
pamp
ligand
step
nov
capsid
bind
hbga
step
overal
conclus
molecular
mechan
step
tabl
suffici
well
understood
present
enabl
quantit
estim
probabl
basi
omic
data
howev
omic
approach
make
major
contribut
specif
area
initi
infect
process
particular
accommod
genet
variat
pathogen
host
popul
extens
sequenc
human
microbiom
includ
gastrointestin
microbiota
play
major
role
protect
infect
step
although
molecular
mechan
establish
genom
sequenc
individu
human
enabl
identif
genet
differ
suscept
nonsuscept
person
may
possibl
futur
tailor
risk
assess
differ
host
popul
term
genet
suscept
initi
infect
promis
applic
genet
marker
defin
proport
host
popul
suscept
initi
infect
specif
pathogen
current
exampl
includ
gene
affect
nov
bind
gastrointestin
tract
step
potenti
polymorph
host
prr
gene
step
wang
et
al
thu
great
strength
genom
sequenc
give
inform
distribut
proport
suscept
genotyp
host
popul
rather
predict
specif
interact
amino
acid
sequenc
concurr
obtain
inde
even
best
character
step
infect
process
name
nov
capsidhbga
bind
step
chang
amino
acid
sequenc
use
predict
chang
bind
specif
affin
furthermor
mani
gap
understand
viral
protein
actual
function
interact
host
cell
protein
also
often
multipl
mechan
altern
molecular
pathway
use
viru
exampl
inhibit
host
gene
express
translat
sar
coronaviru
lokugamag
et
al
potenti
proteom
approach
contribut
understand
viral
protein
interact
multitud
cellular
protein
within
host
cell
particularli
step
host
glycan
play
central
role
pathogen
infect
process
includ
bind
viru
specif
receptor
step
also
immun
system
exampl
hbga
glycan
nov
bind
step
simpl
sens
singl
mutat
gene
gene
code
enzym
synthes
hbga
result
absenc
function
receptor
howev
relationship
involv
glycan
omic
data
simpl
link
singl
mutat
proteincod
gene
suscept
infect
may
except
rather
rule
glycan
complex
structur
may
chang
infect
host
tri
evad
pathogen
also
develop
host
mcguckin
et
al
predict
glycan
structur
dna
sequenc
possibl
current
unlik
gene
express
clear
cell
control
glycan
structur
thu
current
understand
glycoproteom
glycan
function
major
limit
develop
mechanist
drr
virus
ultim
aim
applic
omic
molecular
biolog
approach
would
take
drr
beyond
classic
volunteerderiv
model
infect
broad
group
typic
healthi
individu
realm
predict
diseas
progress
morbid
individu
host
level
base
genet
inform
host
viru
howev
although
genom
approach
may
enabl
consider
viru
dynam
evolv
system
oppos
static
singl
entiti
within
infect
host
predict
progress
rna
viru
term
abil
spread
new
tissu
eg
nervou
system
evad
host
acquir
immun
system
persist
result
chronic
infect
fraught
difficulti
due
complex
pathway
natur
variant
rna
viru
mutant
spectrum
interact
thu
variant
collect
cooper
contribut
characterist
viral
popul
express
differ
phenotyp
trait
abil
predict
outcom
infect
limit
laur
andino
howev
interact
mutant
spectra
could
help
elucid
futur
mechan
higher
exposur
dose
increas
probabl
ill
given
infect
occur
thu
nov
teuni
et
al
report
infect
subject
dosedepend
probabl
becom
ill
rang
dose
genom
genom
genom
data
increas
repertoir
genet
marker
host
viru
give
better
understand
factor
affect
diseas
progress
altern
attempt
use
omic
data
develop
mechanist
drr
ng
may
provid
empir
data
calibr
drr
thu
data
obtain
ng
viru
donor
recipi
host
eg
obtain
nov
bull
et
al
show
great
promis
directli
estim
probabl
infect
virion
avoid
uncertainti
associ
role
viral
protein
glycan
interact
mutant
spectra
ng
viru
donor
recipi
provid
uniqu
insight
infect
process
term
frequenc
variant
initi
infect
demonstr
case
nov
virion
includ
major
variant
initi
infect
bull
et
al
suggest
virion
exposur
low
probabl
infect
ng
shown
differ
virion
highdos
exposur
differ
sequenc
better
adapt
initi
infect
other
bull
et
al
conclus
anticip
omic
approach
make
contribut
specif
area
initi
infect
process
emphasi
omic
approach
togeth
tradit
biochemistri
techniqu
tool
understand
fulli
mechan
step
initi
infect
process
although
seem
certain
extrem
difficult
task
interpret
inform
quantit
genom
data
continu
give
inform
frequenc
gene
affect
suscept
initi
infect
within
host
popul
lack
knowledg
glycan
togeth
difficulti
predict
function
effect
amino
acid
chang
key
protein
pose
challeng
conclud
predict
diseas
progress
given
initi
infect
occur
rna
virus
level
individu
host
possibl
reflect
lack
understand
variabl
viru
evolut
viru
progress
diseas
cooper
differ
clade
mutant
spectra
countermeasur
host
viru
togeth
chanc
factor
howev
molecular
marker
host
viru
may
provid
use
inform
diseas
progress
risk
assess
potenti
use
ng
compar
mutant
spectra
virus
exposur
dose
present
infect
donor
infect
recipi
method
give
direct
estim
probabl
infect
explor
